[Treatment of rheumatic diseases: current status and future prospective. Topics: III. Biological drugs; 5. B cell targeting biologics for rheumatic diseases]

Nihon Naika Gakkai Zasshi. 2011 Oct 10;100(10):2991-7. doi: 10.2169/naika.100.2991.
[Article in Japanese]
No abstract available

Publication types

  • Review

MeSH terms

  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Antibodies, Monoclonal, Murine-Derived / therapeutic use
  • Antirheumatic Agents / therapeutic use*
  • B-Lymphocytes / drug effects*
  • Collagen Diseases / drug therapy*
  • Humans
  • Rheumatic Diseases / drug therapy*
  • Rituximab

Substances

  • Antibodies, Monoclonal, Humanized
  • Antibodies, Monoclonal, Murine-Derived
  • Antirheumatic Agents
  • Rituximab
  • ocrelizumab